Hospital
Iowa Specialty Hospital- Clarion
Iowa Specialty Hospital- Clarion was paid $1.38M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 59025, Fetal non-stress test — 22% of everything it billed.
33Billing provider infoIOWA SPECIALTY HOSPITAL- CLARION
CLARION, IA 50525
CLARION, IA 50525
33aNPI1386671246assigned 06/27/2006
33bProvider typeCritical Access Hospital
28Total paid$1.38M
24GClaims23,537
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Iowa
Rank by total paid#28 of 79
Median peer was paid$801K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,795 | $95K | |
| 2019 | 2,549 | $128K | |
| 2020 | 2,352 | $115K | |
| 2021 | 4,471 | $288K | |
| 2022 | 5,667 | $334K | |
| 2023 | 4,570 | $262K | |
| 2024incomplete | 2,133 | $160K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 59025 | Fetal non-stress test | 22% | 949 | 646 | $298K |
| 36415 | Collection of venous blood by venipuncture | 14% | 7,354 | 6,323 | $196K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 14% | 4,238 | 3,950 | $194K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.0% | 1,080 | 979 | $110K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.9% | 699 | 606 | $95K |
| 80053 | Comprehensive metabolic panel | 6.0% | 1,181 | 1,056 | $83K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.3% | 705 | 652 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.7% | 2,042 | 1,781 | $65K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.4% | 658 | 593 | $48K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 2.6% | 48 | 43 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 274 | 269 | $17K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.1% | 75 | 74 | $15K |
44 more codes
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.1% | 16 | $15K |
| 95806 | <1% | 85 | $13K | |
| 86140 | <1% | 546 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 322 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 322 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 253 | $8K |
| 81003 | <1% | 655 | $7K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 45 | $6K |
| 81001 | <1% | 281 | $6K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 40 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 137 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 189 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 336 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 55 | $4K |
| 87210 | <1% | 160 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 17 | $4K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 19 | $4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 118 | $3K |
| 94060 | <1% | 13 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 42 | $2K |
| 85027 | <1% | 59 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 14 | $2K |
| 86710 | <1% | 18 | $2K | |
| 80061 | Lipid panel | <1% | 27 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 61 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 15 | $1K |
| 83605 | <1% | 26 | $1K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 80 | $814.65 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $628.94 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 13 | $554.79 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 16 | $526.15 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $520.20 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 20 | $342.51 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 33 | $321.79 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 32 | $310.05 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 12 | $258.60 |
| 86803 | <1% | 12 | $250.90 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 29 | $205.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 21 | $193.68 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $157.90 |
| J2704 | Injection, propofol, 10 mg | <1% | 15 | $155.11 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 12 | $19.84 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIMONIN, STEVE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Iowa Specialty Hospital- Clarion | Clarion, IA | $6.84M |
| Iowa Specialty Hospital - Clarion | Fort Dodge, IA | $1.90M |
| Iowa Specialty Hospital- Clarion | Clarion, IA | $801K |
| Iowa Specialty Hospital- Clarion | Clarion, IA | $44.11 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.